Abstract:IntroductionInflammatory vascular syndromes (IVS) are rare but devastating arterial disorders. A lethal IVS model can be induced by mouse gamma herpesviral (MHV68) infection in interferon gamma receptor knockout mice (IFNγR−/−). Previously, a serine protease inhibitor (serpin), virus‐derived Serp‐1 protein and Serp‐1 reactive center loop (RCL) peptide S‐7 (G305TTASSDTAITLIPR319) significantly improved survival and reduced aortic inflammation after MHV68 infection. As the microbiome is reported to have profound effects on immune response, we investigated the role of the gut bacteria in MHV68‐infected IVS mouse models with and without treatment.MethodIFNγR−/− mice (N=56) were split into control or 10‐day antibiotic groups prior to infection with MHV68. Mice were treated with saline, Serp‐1 or RCL peptides S‐2, S‐7, S‐8 or modified S‐7 peptides MPS‐8 and MPS‐9. Fecal pellets were collected and 16S rRNA was Illumina sequenced from genomic DNA extracts.ResultsSuppression of gut bacteria accelerated mortality and reduced survival from 60 to 20 days (P=0.036) in MHV68 IVS. Survival was reduced from 70% at 150 days to 20% at 30 days with Serp‐1 treatment (P=0.003) and 0% at 30 days with S‐7 treatment (P<0.0001), while S‐2 was inactive and S‐8 trended towards improvement (N=14). In contrast, modified S‐7 RL peptides, MPS‐8 and MPS‐9, improved survival after suppression of gut bacteria (P<0.001, N=10). Both Serp‐1 and S‐7 significantly altered microbiome community structure (beta‐diversity), while S‐7 also altered community richness (alpha‐diversity), in the large intestine versus saline controls. Lactobacillales were significantly reduced and Streptophyta increased in MHV68 infection with saline treatment, while Bacillales were significantly reduced and Lactobacillales increased in Serp‐1 treatments. Treatment with normal gut micorbial gavage improved survival after antibiotic suppression of gut bacteria.ConclusionMicrobiome richness, structure, or sub‐population composition, play a crucial role in modulating lethal vasculitic syndromes and treatment response. Serp‐1 and S‐7 show significant therapeutic benefit in MHV68 infection‐induced IVS in mice, which is abolished by gut microbiome suppression. MPS‐8 and MPS‐9 recover efficacy in this model. Significant microbiome changes occurred in Serp‐1‐ and S‐7‐treated, gut bacteria‐suppressed mice.Support or Funding InformationArizona State University ‐ Start up funding American Heart Association Grant in aid National Institutes of Health RO1This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (ifnγr−/−) That is Blocked by Interleukin-10

Immune protection is dependent on the gut microbiome in a lethal mouse gammaherpesviral infection

Modifying Mouse Herpesvirus‐Induced Vasculitis and Serpin Anti‐Inflammatory Treatment ‐ Profound Effects of the Gut Microbiota

Murine γ-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: a new model for virus-induced vascular disease

Murine Gammaherpesvirus 68 Pathogenesis is Independent of Caspase-1 and Caspase-11 in Mice and Impairs Interleukin-1β Production Upon Extrinsic Stimulation in Culture

Mouse mammary tumor virus is implicated in severity of colitis and dysbiosis in the IL-10-/- mouse model of inflammatory bowel disease

Gut Microbiota Determine Severity of Lethal Gammaherpesvirus-Induced Vasculitis and Efficacy of Immune-Modulating Therapy in Mice

Murine gamma herpesvirus 68 hijacks MAVS and IKKβ to abrogate NFκB activation and antiviral cytokine production

Single Cell Transcriptomic Dissection of Virus Induced Immunopathology in Interferon Gamma Receptor Null Mice

The IFN‐inducible GTPase IRGB10 Regulates Viral Replication and Inflammasome Activation During Influenza A Virus Infection in Mice

The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections

Gammaherpesvirus Infection Stimulates Lung Tumor-Promoting Inflammation

Murine gammaherpesvirus 68 genes both induce and suppress lymphoproliferative disease

Longitudinal Single-Cell Transcriptomics of Gamma Herpesvirus Infection in Mouse Lungs

Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection

Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels

The Gut Microbiome Modulates Disease Progression and Anti-Inflammatory Treatment in Mouse Herpesvirus-Induced Vasculitis

γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis

Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB β2 microglobulin-deficient mice

Inhibition of Murine Herpesvirus-68 Replication by IFN-gamma in Macrophages is Counteracted by the Induction of SOCS1 Expression.

Critical role for a high-affinity chemokine-binding protein in γ-herpesvirus–induced lethal meningitis